Axcella Stock Executives

AXLA
 Stock
  

USD 0.87  0.029  3.22%   

Axcella Health employes about 59 people. The company is managed by 14 executives with a total tenure of roughly 4 years, averaging almost 0.0 years of service per executive having 4.21 employees per reported executive. Analysis of Axcella Health management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Axcella Health future performance.
Please continue to Trending Equities.
  
  William Hinshaw  CEO
President CEO
  Bill Hinshaw  CEO
President CEO
  Manu Chakravarthy  President
Senior Vice President of Clinical Development, Chief Medical Officer

Axcella Health Management Team Effectiveness

Axcella Health has return on total asset (ROA) of (0.9192) % which means that it has lost $0.9192 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (5.4323) %, meaning that it created substantial loss on money invested by shareholders. Axcella Health management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Axcella Health Workforce Comparison

Axcella Health is rated second in number of employees category among related companies. The total workforce of Health Care industry is presently estimated at about 209,029. Axcella Health adds roughly 59.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Axcella Health Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axcella Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axcella Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Axcella Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Axcella Health Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Axcella Health Price Series Summation is a cross summation of Axcella Health price series and its benchmark/peer.
.

Axcella Health Notable Stakeholders

An Axcella Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Axcella Health often face trade-offs trying to please all of them. Axcella Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Axcella Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
William Hinshaw - President CEOProfile
Bill Hinshaw - President CEOProfile
Manu Chakravarthy - Senior Vice President of Clinical Development, Chief Medical OfficerProfile
Tony Tramontin - Senior Vice President of Research and Development , Chief Scientific OfficerProfile
Thomas Leggett - CFO, Senior Vice President of FinanceProfile
Stephen Mitchener - Senior Vice President chief Business OfficerProfile
Virginia Dean - VP OfficerProfile
Dan Kirby - VP OperationsProfile
Paul JD - Chief VPProfile
Robert Crane - VP CFOProfile
Laurent Chardonnet - ConsultantProfile
Margaret MD - VP OfficerProfile
Alison MD - Pres OperationsProfile
Larry Bell - Global VPProfile

About Axcella Health Management Performance

The success or failure of an entity such as Axcella Health often depends on how effective the management is. Axcella Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Axcella management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Axcella management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Axcella Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
The data published in Axcella Health's official financial statements usually reflect Axcella Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Axcella Health. For example, before you start analyzing numbers published by Axcella accountants, it's critical to develop an understanding of what Axcella Health's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Axcella Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Axcella Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Axcella Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Axcella Health. Please utilize our Beneish M Score to check the likelihood of Axcella Health's management to manipulate its earnings.

Axcella Health Workforce Analysis

Traditionally, organizations such as Axcella Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Axcella Health within its industry.

Axcella Health Manpower Efficiency

Return on Axcella Health Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.1 M
Net Loss Per Executive4.6 M
Working Capital Per Employee940.5 K
Working Capital Per Executive4 M
Please continue to Trending Equities. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for analysis

When running Axcella Health price analysis, check to measure Axcella Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axcella Health is operating at the current time. Most of Axcella Health's value examination focuses on studying past and present price action to predict the probability of Axcella Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Axcella Health's price. Additionally, you may evaluate how the addition of Axcella Health to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Is Axcella Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axcella Health. If investors know Axcella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axcella Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
66.3 M
Return On Assets
(0.92) 
Return On Equity
(5.43) 
The market value of Axcella Health is measured differently than its book value, which is the value of Axcella that is recorded on the company's balance sheet. Investors also form their own opinion of Axcella Health's value that differs from its market value or its book value, called intrinsic value, which is Axcella Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axcella Health's market value can be influenced by many factors that don't directly affect Axcella Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axcella Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Axcella Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axcella Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.